IE45505L - 1,5-disubstituted-2-pyrrolidones. - Google Patents

1,5-disubstituted-2-pyrrolidones.

Info

Publication number
IE45505L
IE45505L IE771641A IE164177A IE45505L IE 45505 L IE45505 L IE 45505L IE 771641 A IE771641 A IE 771641A IE 164177 A IE164177 A IE 164177A IE 45505 L IE45505 L IE 45505L
Authority
IE
Ireland
Prior art keywords
pyrrolidones
disubstituted
ca1077948a
disubstitued
prostaglandin
Prior art date
Application number
IE771641A
Other versions
IE45505B1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IE654/80A priority Critical patent/IE45506B1/en
Publication of IE45505L publication Critical patent/IE45505L/en
Publication of IE45505B1 publication Critical patent/IE45505B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A series of 1,5-disubstitued-2-pyrrolidones which are prostaglandin-like in character and the processes for making them are disclosed. [CA1077948A]
IE1641/77A 1976-08-06 1977-08-05 1,5-disubstituted-2-pyrrolidones IE45505B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE654/80A IE45506B1 (en) 1976-08-06 1977-08-05 1,5-disubstituted-2-pyrrolidones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (2)

Publication Number Publication Date
IE45505L true IE45505L (en) 1978-02-06
IE45505B1 IE45505B1 (en) 1982-09-08

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1641/77A IE45505B1 (en) 1976-08-06 1977-08-05 1,5-disubstituted-2-pyrrolidones

Country Status (31)

Country Link
JP (2) JPS5321159A (en)
AR (1) AR217080A1 (en)
AT (1) AT362887B (en)
AU (1) AU508007B2 (en)
BE (1) BE857506A (en)
BG (1) BG31073A3 (en)
CA (1) CA1077948A (en)
CH (1) CH624934A5 (en)
CS (1) CS221269B2 (en)
DD (2) DD136135A5 (en)
DE (1) DE2735904A1 (en)
DK (1) DK352077A (en)
ES (2) ES461388A1 (en)
FI (1) FI70009C (en)
FR (1) FR2369260A1 (en)
GB (2) GB1556570A (en)
GR (1) GR68688B (en)
HU (1) HU180273B (en)
IE (1) IE45505B1 (en)
IL (1) IL52615A (en)
LU (1) LU77936A1 (en)
NL (1) NL7708637A (en)
NO (1) NO772752L (en)
NZ (1) NZ184806A (en)
PH (1) PH17398A (en)
PL (2) PL200124A1 (en)
PT (1) PT66891B (en)
SE (1) SE423813B (en)
SU (3) SU703016A3 (en)
YU (1) YU192577A (en)
ZA (1) ZA774704B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
ATE327751T1 (en) * 2000-01-31 2006-06-15 Pfizer Prod Inc USE OF PROSTAGLAND RECEPTOR 4 ACTIVATORS FOR THE TREATMENT OF ACUTE OR CHRONIC RENAL INSUFFICIENCY
WO2002024647A1 (en) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
CA2429850C (en) * 2000-11-27 2008-12-30 Pfizer Products Inc. Ep4 receptor selective agonists in the treatment of osteoporosis
PT1417975E (en) * 2001-07-23 2011-05-30 Ono Pharmaceutical Co Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
MXPA04005555A (en) * 2002-03-18 2005-05-16 Pfizer Prod Inc Methods of treatment with selective ep4 receptor agonists.
US6573294B1 (en) 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
JP4582456B2 (en) * 2003-01-21 2010-11-17 小野薬品工業株式会社 8-Azaprostaglandin derivatives and pharmaceutical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (en) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22PIRORIDONJUDOTAINO SEIHO
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (en) * 1975-06-27 1977-01-13 Hoechst Ag PYRROLIDONE AND THE METHOD FOR MANUFACTURING THEIR

Also Published As

Publication number Publication date
JPS5321159A (en) 1978-02-27
BG31073A3 (en) 1981-10-15
LU77936A1 (en) 1978-04-27
JPS585196B2 (en) 1983-01-29
FI772376A7 (en) 1978-02-07
IL52615A0 (en) 1977-10-31
FR2369260B1 (en) 1982-02-12
GR68688B (en) 1982-02-01
BE857506A (en) 1978-02-06
CS221269B2 (en) 1983-04-29
DE2735904A1 (en) 1978-02-09
DD136135A5 (en) 1979-06-20
NZ184806A (en) 1980-04-28
PL200124A1 (en) 1978-05-22
DD143768A5 (en) 1980-09-10
SE423813B (en) 1982-06-07
SU818480A3 (en) 1981-03-30
PT66891B (en) 1979-01-26
AU508007B2 (en) 1980-03-06
ES461388A1 (en) 1978-12-01
PT66891A (en) 1977-09-01
GB1556569A (en) 1979-11-28
HU180273B (en) 1983-02-28
CA1077948A (en) 1980-05-20
ES471349A1 (en) 1979-09-16
JPS5531147B2 (en) 1980-08-15
AR217080A1 (en) 1980-02-29
IE45505B1 (en) 1982-09-08
DK352077A (en) 1978-02-07
AT362887B (en) 1981-06-25
SE7708642L (en) 1978-02-07
ATA579477A (en) 1980-11-15
CH624934A5 (en) 1981-08-31
JPS5555161A (en) 1980-04-22
SU703016A3 (en) 1979-12-05
ZA774704B (en) 1978-06-28
IL52615A (en) 1981-09-13
GB1556570A (en) 1979-11-28
PL112931B1 (en) 1980-11-29
AU2751577A (en) 1979-02-08
FR2369260A1 (en) 1978-05-26
FI70009B (en) 1986-01-31
FI70009C (en) 1986-09-12
NO772752L (en) 1978-02-07
NL7708637A (en) 1978-02-08
SU850000A3 (en) 1981-07-23
PH17398A (en) 1984-08-08
YU192577A (en) 1983-04-30

Similar Documents

Publication Publication Date Title
AU508612B2 (en) 8 c 1. a r C
AU503557B2 (en) N, n' alkylene-bis-tetrabromo-phthalimides
AU503871B2 (en) 1. 2-benzothiazolin-3-one
IE45505L (en) 1,5-disubstituted-2-pyrrolidones.
AU2668177A (en) 2, 6-Methano-2H-l-Benzoxocins
AU512313B2 (en) y, y, Disubstituted-5-valerolactones
AU500386B2 (en) 1,2,6-thidiazinones
AU515495B2 (en) 5, 5-trimethylhexanoyl-ferrocene
AU511988B2 (en) O-ethyl-s-n-propyl-0,2,2,2-trihaloethy_phosphoro-thiolates/thionothiolates
AU505974B2 (en) 3', 4'-dideoxykanamcin b
GB1541546A (en) 1-aminitricyclo 4.3.1.1 2,5 undecane and process for the preparation thereof
IE41600L (en) 3, 4 - dihydro - 2h - isoquinolin - 1 - thiones
GB1541544A (en) 1-halogenotricyclo 4.3.1.1 2,5 undecane and process for the preparation thereof
AU517895B2 (en) 1, 3-dihydro-1-dimethyl phosphinylalkyl 3 phenylspiro ( iosbenzofurn)s
GB1541545A (en) 1-acetylaminotricyclo 4.3.1.1 2,5 undecane and process forthe preparation thereof
AU511827B2 (en) 5-anyl-3, 6-dihydro-l, 3, 4-oxadiazin-2-ones
AU507282B2 (en) 3, 3-Dimethylpent-4-Endic Acid
MY8200244A (en) 2,3-dihydro-2-oxo-3-benzo[b]thiophenecarboxides
AU514741B2 (en) 5,6-dehydropenicillins
CS191036B1 (en) 4,./10/-gonadienes and method for the preparation thereof
AU3073477A (en) Manufacture of 1, 1 Dihalo-4-methyl-l., 3-pentadienes
AU524600B2 (en) 2,6-methano-3-benzazocines
AU488952B2 (en) 2. 4-diamino-5-benzylpyrimidines
AU520088B2 (en) 1, 2, 3, 4-tetrahydro-naphthalenes
AU492181B2 (en) 13,14-dehydro-11-deoxy-prostaglandins and process for their preparation